ANAVEX New Website - Untitled Page.png

About ANAVEX

Anavex Life Sciences Corp. (Nasdaq: AVXL) is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and development of targeted CNS treatments.

Our Values

Precision Therapeutics

Brain Mono.png

Community-based Insights

Community v3 Mono.png

  Scientific   Innovation

Innovation v3 Mono.png

Inclusion & Equitable Access

Inclusion v3 Mono.png
 

Our Team

 

Management

Christopher U. Missling, PhD, MS, MBA
Walter E Kaufmann, MD
Stephan Toutain, MS, MBA
Edward Hammond, PhD, MD
Emmanuel O Fadiran, RPh, MS, PhD
Daniel Klamer, PhD, MS, MBA
Adebayo Laniyonu, PhD

Directors

Christopher U. Missling, PhD, MS, MBA
Claus van der Velden, PhD
Peter Donhauser, DO
Steffen Thomas, PhD
Tom Skarpelos
Jiong Ma, PhD

Scientific Advisors

Jeffrey Cummings, MD
Norman Relkin, MD, PhD
Daniel Weintraub, MD
Andrew J. Cole, MD, FRCP(C)
John Harrison, PhD
Paul Aisen, MD
Dag Aarsland, MD, PhD
Jacqueline French, MD, FAAN
Corinne Lasmézas, PhD, DVM
Ottavio Arancio, MD, PhD
Tangui Nicolas Maurice, PhD

Quick Links

Home

Therapeutic Candidates

Investors

News

Patients & Carers

Contact Us

Resources

About Us

SIGMACEPTOR™ 

Corporate Presentation

Forward-Looking Statements

Legal Notice

Privacy Policy

New Logo white .png

Join our mailing list

Thank you for subscribing!

ANAVEX® is a trademark of Anavex Life Sciences Corp. © 2007-2022. All Rights Reserved.